Resources
Explore how healthcare organizations, researchers, and life sciences partners from our global community use TriNetX to turn real-world patient data into evidence that drives progress.
COVID-19 caused or exacerbated negative health outcomes for many people, especially for those with pre-existing comorbidities. Sickle cell disease (SCD) is a rare genetic condition that primarily occurs among African Americans in the United States.
The MetroHealth System, Cuyahoga County’s public health system, provides care to more than 300,000 patients through nearly 1.5 million visits a year at its four hospitals, and more than 20 health centers throughout the county, which includes Cleveland and surrounding suburbs
As the COVID-19 pandemic raged, the healthcare industry was rightfully focused on treating the devastating acute symptoms of the disease.
Penn State College of Medicine is a national leader in pursuing basic, clinical, translational and health services research. Penn State is ranked in the top one percent of the world’s universities, and the College of Medicine boasts a portfolio of nearly $100 million in funded research.
The University of Texas Medical Branch (UTMB) Health’s Blocker Burn Center in Galveston, Texas is nationally and internationally recognized for specialization in the treatment of thermal, chemical and radiation burns.
The West Virginia Clinical and Translational Science Institute (WVCTSI), a partner of West Virginia University (WVU), is an academic home and a catalyst for clinical and translational research that targets priority health areas including addiction and resulting emerging epidemics such as hepatitis C, cancer, cardiovascular disease, and chronic lung disease.
Clinical trials, whether industry, cooperative group sponsored, or investigator initiated, have an unacceptable rate of failure as a result of the inability to recruit sufficient numbers of patients.
Upcoming Webinar
From Data to Evidence: A Framework for RWD Study Design & Causal Inference
Thursday, July 16 | 11am ET
Generating credible evidence from real-world data (RWD) requires more than access to data — it demands intentional alignment between the research question, study design, and data source. Yet even experienced teams fall into the trap of starting with the data and working backward, a shortcut that can undermine the trustworthiness of study findings.
Join TriNetX Chief Scientific Officer Jeffrey Brown, PhD, and Miguel Hernán, MD, PhD, ScD, Director of CAUSALab at Harvard, as they walk through a practical framework for designing rigorous RWD studies for causal inference. Attendees will leave with concrete tools for sequencing their research approach, evaluating data fitness, and applying sound decision-making to their own studies.
Join a global community of innovators. Discover how to turn real-world data into groundbreaking clinical insights.
Meet TriNetX at Events
Bridge the gap between raw data and patient care. Meet the team at flagship healthcare conferences across the globe, and learn how to leverage the TriNetX ecosystem to streamline trial timelines, improve site collaboration, and publish research that changes lives.
